Ascendis Pharma A/S
NasdaqGS:ASND
$ 220,48
$-6,21 (-2,74%)
220,48 $
$-6,21 (-2,74%)
End-of-day quote: 04/07/2026

Quick Analysis
The traffic-light system summarizes key characteristics and shows the investment’s quality at a glance.

$-4,41
Earnings Per Share
$13,78
Revenue Per Share
86,82%
Gross Margin %
$13,53 B
Market Cap
$0,30 B
Long-Term Debt
Earnings Per Share
$-4,41
Revenue Per Share
$13,78
Gross Margin %
86,82%
Market Cap
$13,53 B
Long-Term Debt
$0,30 B

Financials

Year Year 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
EPS Earnings Per Share $-4,41 $-6,76 $-9,45 $-11,11 $-7,96 $-10,13 $-5,26 $-3,63 $-4,42 $-2,72 $-1,51 $-1,30
Earnings Earnings $-270,69M $-404,52M $-534,96M $-622,60M $-451,97M $-544,49M $-252,43M $-152,97M $-183,52M $-88,18M $-37,95M $-30,99M
RPS Revenue Per Share $13,78 $6,29 $5,21 $0,98 $0,16 $0,16 $0,31 $0,29 $0,04 $0,15 $0,35 $0,71
Revenue Revenue $845,52M $376,48M $294,81M $54,69M $8,85M $8,51M $15,01M $12,11M $1,84M $4,86M $8,82M $16,93M
OCF Operating Cash Flow $-23,56M $-317,01M $-516,59M $-529,76M $-474,98M $-332,17M $-207,60M $-163,76M $-121,40M $-67,82M $-42,96M $0,00M
FCF Free Cash Flow $148,02M $-318,48M $-519,29M $-545,25M $-501,94M $-356,46M $-213,39M $-166,79M $-115,32M $-64,24M $-48,34M $0,00M
OM Operating Margin -18,92% -76,66% -170,79% 0,00% 0,00% 0,00% 0,00% 0,00% 0,00% 0,00% 0,00% -85,74%
GM % Gross Margin % 86,82% 87,83% 83,36% 76,28% 54,71% 100,00% 100,00% 100,00% 100,00% 100,00% 100,00% 100,00%
FCFS Free Cash Flow Per Share $0,88 $-5,50 $-9,23 $-9,10 $-9,18 $-7,08 $-4,37 $-3,94 $-3,43 $-2,42 $-2,03 $-2,00
LT Debt Long-Term Debt $298,42M $297,68M $152,95M $387,56M N/A N/A N/A N/A N/A N/A N/A N/A
Sha. Stocks 61,38M 59,84M 56,61M 56,04M 56,78M 53,75M 47,99M 42,14M 41,52M 32,42M 25,13M 23,84M
×